| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $2.17 (Beat by $0.32) |
| EPS GAAP Actual | $2.17 (Beat by $0.32) |
| Revenue Actual | $2.9202B |
| Revenue Surprise | Beat by $2920.2M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.43064 |
| EPS GAAP Estimate | $2.43064 |
| Revenue Estimate | $3.051913436B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 15.6859 | 8.87 | 14.96729 | 16.33247 | 3 |
| Dec 2028 | 8.60935 | 16.15 | 8.41691 | 8.89063 | 7 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.3 | -1.62797 | 2.9202B | 1.13% | -276.99M |
| FQ3 2025 (Sep 2025) | 4.1 | 1.19454 | 2.4763B | -4.97% | -953.6M |
| FQ2 2025 (Jun 2025) | 4.22 | 0.9093 | 2.635B | -23.21% | -771.28M |
| FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 2.0505B | -42.83% | 2050.5M |
| FQ4 2024 (Dec 2024) | -3.43 | -3.43 | 2.8873B | -31.64% | 2887.3M |
| FQ3 2024 (Sep 2024) | 0.4 | 0.4 | 2.5993B | -32.94% | 2599.3M |
| FQ2 2024 (Jun 2024) | -4.92 | -4.92 | 3.2466B | -17.74% | 3246.6M |
| FQ1 2024 (Mar 2024) | 2.25 | 2.25 | 2.9287B | -13.82% | 2928.7M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.43064
Consensus Revenue Estimates
3.051913436B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.70656 | -- | 2.50321 | 2.83344 | 5 |
| FQ3 2027 (Sep 2027) | 2.00941 | -- | 1.87073 | 2.19094 | 4 |
| FQ2 2027 (Jun 2027) | 1.89345 | -- | 1.76277 | 2.0645 | 4 |
| FQ1 2027 (Mar 2027) | 0.97178 | -- | 0.90542 | 1.06037 | 4 |
| FQ4 2026 (Oct 2026) | 3.21683 | 59.59 | 3.08075 | 3.31518 | 3 |
| FQ3 2026 (Jul 2026) | 3.26923 | -25.41 | 3.13093 | 3.36918 | 4 |
| FQ2 2026 (Jun 2026) | 3.53084 | -19.52 | 3.31851 | 3.63366 | 4 |
| FQ1 2026 (Mar 2026) | 2.43064 | 94.24 | 2.28447 | 2.50142 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.1B | -- | 2.92B | 3.21B | 5 |
| FQ3 2027 (Sep 2027) | 2.48B | -- | 2.34B | 2.65B | 5 |
| FQ2 2027 (Jun 2027) | 2.64B | -- | 2.5B | 2.82B | 4 |
| FQ1 2027 (Mar 2027) | 2.07B | -- | 1.96B | 2.22B | 8 |
| FQ4 2026 (Oct 2026) | 3.35B | 12.9 | 3.24B | 3.43B | 4 |
| FQ3 2026 (Jul 2026) | 3.61B | 31.47 | 3.5B | 3.7B | 5 |
| FQ2 2026 (Jun 2026) | 3.61B | 26.91 | 3.44B | 3.69B | 5 |
| FQ1 2026 (Mar 2026) | 3.05B | 32.81 | 2.91B | 3.12B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.92797 | 1.3 | -1.62797 | -125.23% |
| FQ3 2025 (Sep 2025) | 2.90546 | 4.1 | 1.19454 | 29.14% |
| FQ2 2025 (Jun 2025) | 3.3107 | 4.22 | 0.9093 | 21.55% |
| FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 100% | |
| FQ4 2024 (Dec 2024) | -3.43 | -3.43 | 100% | |
| FQ3 2024 (Sep 2024) | 0.4 | 0.4 | 100% | |
| FQ2 2024 (Jun 2024) | -4.92 | -4.92 | 100% | |
| FQ1 2024 (Mar 2024) | 2.25 | 2.25 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $3.2B | $2.92B | $-276.99M | -9.49% |
| FQ3 2025 (Sep 2025) | $3.43B | $2.48B | $-953.6M | -38.51% |
| FQ2 2025 (Jun 2025) | $3.41B | $2.64B | $-771.28M | -29.27% |
| FQ1 2025 (Mar 2025) | $0B | $2.05B | $2050.5M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.89B | $2887.3M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.6B | $2599.3M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $3.25B | $3246.6M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.93B | $2928.7M | 100% |